Rockville-based Supernus Pharmaceuticals, headquartered at 9715 Key West Ave., has announced plans to merge with Indivior Pharmaceuticals in a deal that will create a larger company focused on developing and selling medications that treat conditions affecting the brain and nervous system, including neurological disorders, mental health conditions and addiction.